Showing 7931-7940 of 20878 results for "".
Etiology and Treatment for Diabetic Macular Edema
https://reachmd.com/programs/focus-on-diabetes/etiology-and-treatment-for-diabetic-macular-edema/3836/Almost a third of all type I and type II diabetics develop macular edema. Join host Dr. Bruce Bloom and his guest, ophthalmologist, researcher and vitreo-retinal surgeon Dr. Mary Elizabeth Hartnett, professor of opthamology at the University of North Carolina at Chapel Hill School of Medicine, as thChallenges in Management of MPS I
https://reachmd.com/programs/clinicians-roundtable/challenges-in-management-of-mps-i/4760/Mucopolysaccharidosis I, or MPS I, often presents initially as a child's failure to thrive, and is a diagnosis with devastating effects. How is new research able to help children with this lysosomal storage disorder? Host Dr. Bruce Bloom talks with Dr. David A. Pearce, director of the Sanford ChildrDysregulation of Type 2 Immune Pathway
https://reachmd.com/videos/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.Diabetes Nutrition
https://reachmd.com/programs/clinicians-roundtable/diabetes-nutrition/1918/As the epidemic of obesity continues to grow, we can expect that the prevalence of diabetes will rise accordingly. The age distribution of type 2 diabetes is moving younger and younger. What can we do to stop these alarming trends? certified diabetes educator Jeannee Diaz discusses diabetes nutritiToward a Healthier Journey for the Type 2 Diabetes Patient
https://reachmd.com/programs/diabetes-discourse/toward-a-healthier-journey-for-the-type-2-diabetes-patient/7585/Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed toPharmacist Perspectives on the Challenging Type 2 Diabetic Patient in Primary Care
https://reachmd.com/programs/primary-care-today/pharmacist-perspectives-challenging-type-2-diabetic-patient-primary-care/7611/How can pharmacy practice inform the primary care and family medicine communities about approaching challenging diabetes cases? Christa George, Pharm.D, Associate Professor in the departments of Clinical Pharmacy and Family Medicine at the University of Tennessee Health Science Center, joins Dr. BriFunding for Type1 Diabetes Cure Research
https://reachmd.com/programs/clinicians-roundtable/funding-for-type1-diabetes-cure-research/1836/Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research is funded.Juvenile Diabetes Research Foundation
https://reachmd.com/programs/clinicians-roundtable/juvenile-diabetes-research-foundation/1876/Join Dr. Lou Philipson from the University of Chicago and Amy Franze, the Executive Director of the Illinois JDRF, to discuss type 1 diabetes.How Different Types of Influenza Vaccines Are Made
https://reachmd.com/programs/vaccination/how-different-types-of-influenza-vaccines-are-made/15000/Join us as an expert breaks down the manufacturing process for the various types of influenza vaccines.The Diabetic Investor
https://reachmd.com/programs/clinicians-roundtable/the-diabetic-investor/1642/Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Should you invest in the Diabetes Sector? What drug companies will pick up the Avandia business? Find out in this segment.